Seattle-based life sciences company RareCyte announced $20 million in new funding to advance its applications for the analysis of cells. RareCyte sells imaging-based liquid and tissue biopsy analysis platforms that detect and analyze cells. The company’s products are primarily aimed at clinical and translational researchers in academia and biopharma companies.
Founded in 2009, RareCyte is led by CEO and President Joe Victor, former chairman at Purigen Biosystems and CEO at Startide Sciences.
Seattle-based RareCyte Raises $20M for Cell Analysis Products
Share: